Inovio Pharmaceuticals, Inc. · NASDAQ:INO

Sumner Michael John exercised options for 9,450 Inovio Pharmaceuticals, Inc. shares (Form 4)

Traded May 20, 2026 · Filed May 21, 2026

On May 20, 2026, Sumner Michael John (Chief Medical Officer) exercised options for 9,450 Inovio Pharmaceuticals, Inc. shares, leaving 42,038 shares. Filed May 21, 2026 (Form 4).

Options exercised
9,450 shares
Holding after
42,038 shares
Trading plan
No
Role
Chief Medical Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 20, 2026Common StockOption exercise9,45044,731Direct
May 20, 2026Common StockShares withheld for tax2,693US$1.2342,038Direct

Source

View original at SEC

Related